Drug Healthcare And Patient Safety
期刊中文名：藥物保健和患者安全ISSN：1179-1365
該雜志國(guó)際簡(jiǎn)稱：DRUG HEALTHC PATIENT，是由出版商Dove Medical Press出版的一本致力于發(fā)布--研究新成果的的專業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果，扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展，選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論，促進(jìn)學(xué)術(shù)發(fā)展，為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有很高的學(xué)術(shù)影響力。
雜志介紹
Drug Healthcare And Patient Safety雜志介紹
《Drug Healthcare And Patient Safety》是一本以English為主的開放獲取國(guó)際優(yōu)秀期刊，中文名稱藥物保健和患者安全，本刊主要出版、報(bào)道領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.2，最新CiteScore 指數(shù)為4.1。
英文介紹
Drug Healthcare And Patient Safety雜志英文介紹
Drug Healthcare And Patient Safety covers a wide range of topics from basic research to clinical practice to policy development. It provides a valuable information exchange platform for healthcare professionals, drug developers, policy makers and patients worldwide. The journal focuses on how scientific research can improve the safety and effectiveness of drug use, reduce medical errors, and optimize patient care.
The journal encourages interdisciplinary research, including but not limited to pharmacoepidemiology, pharmacoeconomics, drug safety monitoring, medical technology evaluation, and the organization and management of health care services. It publishes research that not only contributes to understanding the mechanisms of action of drugs in different populations, but also addresses how to improve the delivery of healthcare services through a systematic approach. The audience is broad, including clinicians, pharmacists, caregivers, public health experts, healthcare administrators, and healthcare policy analysts. The articles published in the journal are rigorously peer-reviewed, ensuring that the research is scientific and practical, and has important implications for improving the quality of healthcare and patient safety.
JCR分區(qū)（2023-2024年最新版）
Drug Healthcare And Patient Safety雜志 JCR分區(qū)信息
| 按JIF指標(biāo)學(xué)科分區(qū) |
學(xué)科：HEALTH CARE SCIENCES & SERVICES
收錄子集：ESCI
分區(qū)：Q2
排名：83 / 174
百分位：
52.6% |
| 按JCI指標(biāo)學(xué)科分區(qū) |
學(xué)科：HEALTH CARE SCIENCES & SERVICES
收錄子集：ESCI
分區(qū)：Q3
排名：107 / 175
百分位：
39.14% |
JCR分區(qū)：JCR分區(qū)來自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具，為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū)，設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū)，分別為Q1、Q2、Q3和Q4，各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。
CiteScore 評(píng)價(jià)數(shù)據(jù)（2024年最新版）
Drug Healthcare And Patient Safety雜志CiteScore 評(píng)價(jià)數(shù)據(jù)
- CiteScore 值：4.1
- SJR：0.571
- SNIP：1.145
| 學(xué)科類別 | 分區(qū) | 排名 | 百分位 |
| 大類：Medicine 小類：Health Policy | Q2 | 105 / 310 |
66% |
| 大類：Medicine 小類：Pharmacology | Q3 | 171 / 313 |
45% |
歷年影響因子和期刊自引率
投稿經(jīng)驗(yàn)
Drug Healthcare And Patient Safety雜志投稿經(jīng)驗(yàn)
該雜志是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有較高的學(xué)術(shù)影響力，行業(yè)關(guān)注度很高，已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高，對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高，作為一本國(guó)際優(yōu)秀雜志，一般投稿過審時(shí)間都較長(zhǎng)，投稿過審時(shí)間平均 16 Weeks ，如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單，建議您投稿。如您想了解更多投稿政策及投稿方案，請(qǐng)咨詢客服。
免責(zé)聲明
若用戶需要出版服務(wù)，請(qǐng)聯(lián)系出版商。